Stocks To Watch: Aeropostale Inc (ARO), MGIC Investment Corp. (MTG) and Arena Pharmaceuticals, Inc. (ARNA)

Posted by Saimoon May 4, 2015 0 Comment 530 views


New York, NY – GDP INSIDER  –  05/04/2014.

This article discusses three companies: Aeropostale Inc (NYSE:ARO), MGIC Investment Corp. (NYSE:MTG) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Aeropostale Inc (NYSE:ARO) continued to decline during its last trading session on Friday with the stock closing down 0.32% or $0.01 at $3.08 on light trading volume of 0.953 million shares, compared to its three month average trading volume of 1.87 million shares. The mall based retailer of casual apparel is down 37% over the last 52 weeks, but has rallied this year and is now outperforming the S&P with the stock up 33% year to date, compared to the S&P 500 which has only gained 2.40% since the beginning of the year, making Aeropostale Inc a promising hold for now.

Will Aeropostale Inc Continue To Recover? Take A Closer Look With Our Free ARO Analysis.

MGIC Investment Corp. (NYSE:MTG) continued to decline on Friday with the stock closing down 0.58% or $0.05 to finish the day at a closing price of $10.36 on low trading volume of 3.895 million shares compared to its three month average trading volume of 5.241 million. The US-based private mortgage insurer has been outperforming the S&P 500 so far this year, with the stock climbing 11.16% compared to the index, which is up only 2.40% for the same period. In addition, the RSI and MFI are 57 and 53, respectively. Both of these indicate that the stock is not overvalued at the current levels and the money is flowing in the right direction and still has room to improve.

Where Is MGIC Investment Corp Heading? Buying Into MTG Now Could Help Your Portfolio, Click Here To See How.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) lost two cents to move to a new closing price of $4.34, a slight 0.46% decrease in value from its previous closing price. The stock had a low trading volume of 3.74 million, a figure which is substantially lower than its three month average trading volume of 4.33 million. Arena Pharmaceuticals has been falling steadily for most of the last 52 weeks with the stock down 34.83%, but has been starting to gain back some of these losses since the beginning of the year with the stock up 25% year to date The RSI of 46 indicates the stock is not overvalued, the MFI of 40 shows that money is flowing in the right direction and still has room to improve.

Why Arena Pharmaceuticals, Inc’s Risk/Reward Is Compelling For Investors? Click Here To Read Our Free ARNA Analysis.

About Ultimate Stock Alerts

UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit www.UltimateStockAlerts.com

Disclosure:  UltimateStockAlerts.com is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment